Additionally, GBM was exposed to hypoxia-induced CAIX transcriptional activity, and GBM cells treated with an HIF-1α inhibitor reversed the hypoxia-enhanced CAIX expression (Figure 1K). The gene discussed is CA9; the disease is glioblastoma.